Hi team, thank you for the opportunity. So, my question is, out of the key products that we sell in U.S., the highest contribution is from MMA. You had already resumed sales of MMA in Q3 to U.S. and in fact, you did record volumes there in Q3. So, was there any tariff applying to MMA? That is my first question?
Was it not part of the Annex 2? Because maybe I checked it wrong. I think I got it in the Annex 2 list that was published in November.
Thank you for the opportunity. While we do understand that the pricing pressure is there on the other markets, but in the U.K. after the discontinuation of soda ash, we had been guiding around INR 250 crores of EBITDA for FY26, from the fixed cost savings, etc., and a positive PAT by Q3. So, our 9-month EBITDA is about INR 110 crores. Q3, as I understand, seems to have a one-time impact. But when can we get to the guided EBITDA of INR 250 crores or about INR 60 crores-INR 65 crores quarterly EBITDA run rate and a positive PAT there?
All right. So, that's helpful. Thank you so much.
Good evening and thank you so much for this opportunity. So, my first question is on, you mentioned in your opening remarks and the presentation that prices continued to weaken during Q1 and the overall global demand is also estimated to be flat in the near term. So, if you could give some color on the extent of the price decline that we have seen in Q1 and Q2 so far? And what would that mean for Company profitability going forward, region-wise, if possible, given that India has some benefit o f MIP till December, but for the other regions, how is it likely to play out?
Sure. And sir, sequentially, the India business and even the U.S. business witnessed a decline in volumes. So, what exactly drove the improvement in profitability for both these markets? If you could just give some color. And I understand, prices you mentioned in the opening remarks.
My first question is on the agrochemical capex of INR250 crore, that's for 12,000 metric tonnes. So, assuming 1 point per metric tonne, this appears to be a sub-$3 product. Can you give some colour if it's an existing product or a new product? And if you could also clarify any particular reason for capex in lower value products?
But is this an existing product? Or is it a new product completely?